Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,011 GBX | -0.11% | +6.73% | +13.45% |
03:34pm | ASTRAZENECA : Deutsche Bank gives a Neutral rating | ZD |
29/04 | J&J, Bristol Myers lose challenges to US drug price negotiation program | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.45% | 234B | |
+35.45% | 664B | |
+28.45% | 567B | |
-7.05% | 354B | |
+19.62% | 330B | |
+3.61% | 286B | |
+4.98% | 199B | |
-10.14% | 196B | |
-5.26% | 148B | |
-10.78% | 145B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Merck & Co.'s Prostate Cancer Drug Extends Lives in Late-Stage Study